|
CCDC91 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.121900E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.515200E-01 |
| Normal-vs-Stage2 |
2.710200E-01 |
| Normal-vs-Stage3 |
1.096040E-01 |
| Normal-vs-Stage4 |
5.760300E-03 |
| Stage1-vs-Stage2 |
4.996600E-01 |
| Stage1-vs-Stage3 |
2.083600E-01 |
| Stage1-vs-Stage4 |
8.617300E-03 |
| Stage2-vs-Stage3 |
6.265800E-01 |
| Stage2-vs-Stage4 |
2.558100E-02 |
| Stage3-vs-Stage4 |
5.162400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.081730E-03 |
| Normal-vs-AfricanAmerican |
3.221300E-03 |
| Normal-vs-Asian |
2.427600E-01 |
| Caucasian-vs-AfricanAmerican |
2.63060000005311E-06 |
| Caucasian-vs-Asian |
4.020700E-03 |
| AfricanAmerican-vs-Asian |
5.115000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.391600E-04 |
| Normal-vs-Female |
9.708400E-01 |
| Male-vs-Female |
8.780800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.505800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.335610E-01 |
| Normal-vs-Age(61-80Yrs) |
1.852450E-02 |
| Normal-vs-Age(81-100Yrs) |
2.238400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.586400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.039800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.918200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.105200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.551600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.754800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.81370000129633E-08 |
| Normal-vs-Grade 2 |
5.754600E-01 |
| Normal-vs-Grade 3 |
1.839630E-02 |
| Normal-vs-Grade 4 |
9.242600E-04 |
| Grade 1-vs-Grade 2 |
5.421100E-04 |
| Grade 1-vs-Grade 3 |
1.183280E-04 |
| Grade 1-vs-Grade 4 |
2.14629999994997E-06 |
| Grade 2-vs-Grade 3 |
6.175500E-02 |
| Grade 2-vs-Grade 4 |
2.163500E-03 |
| Grade 3-vs-Grade 4 |
4.111200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.784000E-02 |
| Normal-vs-ccB subtype |
8.435100E-04 |
| ccA subtype-vs-ccB subtype |
1.383480E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.630200E-02 |
| Normal-vs-N1 |
2.007000E-01 |
| N0-vs-N1 |
7.028400E-01 |
|
|
